Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
The Journal of Clinical Investigation|August 16, 2021
Epigenetic modifiers synergize with immune-checkpoint blockade to enhance long-lasting antitumor efficacyMarina Baretti, Mark YarchoanImmunity|April 9, 2025
More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockadeDaniel H Shu, Mark YarchoanDiabetes|June 17, 2014
Repurposing diabetes drugs for brain insulin resistance in Alzheimer diseaseMark Yarchoan, Steven E ArnoldCureus|August 9, 2024
A Case of Recurrence of Fibrolamellar Hepatocellular Carcinoma After 18 Years Underscores the Need for Extended Patient SurveillanceElsa Hallab, Mark Yarchoan, Marina BarettiNature Reviews. Cancer|May 16, 2025
Recent advances in therapeutic cancer vaccinesNeeha Zaidi, Elizabeth M Jaffee, Mark YarchoanCureus|November 29, 2019
Successful Treatment of Scar Pain with Scrambler TherapyMark Yarchoan, Jarushka Naidoo, Thomas J SmithCurrent Oncology Reports|February 6, 2021
Tumor and Systemic Immunomodulatory Effects of MEK InhibitionLauren Dennison, Aditya A Mohan, Mark YarchoanEuropean Journal of Cancer (Oxford, England : 1990)|April 13, 2020
Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging conceptsJean-David Fumet, Caroline Truntzer, Mark Yarchoan, et al.Cureus|January 30, 2016
Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term SurvivalMark Yarchoan, Michael Lim, Julie R Brahmer, et al.Frontiers in Immunology|May 31, 2022
Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular CarcinomaHaoyang Mi, Won Jin Ho, Mark Yarchoan, et al.Pageof 14